After analyzing the tumor microenvironment and the expression pattern of MAGE antigens, we moved to immunohistochemical studies of MAGE-A1, MAGE-3, and MAGE-C2 expression on melanoma tumors subjected to nsPEF. The gene discussed is MAGEA3; the disease is melanoma.